Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Combined intra-arterial infusion and systemic chemoradiotherapy for stage IV squamous cell carcinoma of the mandibular gingiva.

Nakasato T, Izumisawa M, Akahane A, Kikuchi K, Ehara S, Shoji S, Kogi S, Mizuki H, Sugiyama Y.

Jpn J Radiol. 2012 Nov;30(9):752-61. doi: 10.1007/s11604-012-0122-3. Epub 2012 Sep 1.

PMID:
22936237
2.

Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma.

Mukai Y, Hata M, Mitsudo K, Koike I, Koizumi T, Oguri S, Kioi M, Omura M, Tohnai I, Inoue T.

Strahlenther Onkol. 2014 Feb;190(2):181-5. doi: 10.1007/s00066-013-0468-1. Epub 2013 Nov 23.

PMID:
24264464
3.

Radiotherapy and concomitant intra-arterial docetaxel combined with systemic 5-fluorouracil and cisplatin for oropharyngeal cancer: a preliminary report--improvement of locoregional control of oropharyngeal cancer.

Oikawa H, Nakamura R, Nakasato T, Nishimura K, Sato H, Ehara S.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):338-42. doi: 10.1016/j.ijrobp.2009.02.084.

PMID:
19735860
4.

Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.

Fukada J, Shigematsu N, Takeda A, Ohashi T, Tomita T, Shiotani A, Kunieda E, Kawaguchi O, Fujii M, Kubo A.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):417-24. doi: 10.1016/j.ijrobp.2009.01.056. Epub 2009 May 4.

PMID:
19409727
5.

Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.

Mitsudo K, Shigetomi T, Fujimoto Y, Nishiguchi H, Yamamoto N, Furue H, Ueda M, Itoh Y, Fuwa N, Tohnai I.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1428-35. doi: 10.1016/j.ijrobp.2010.01.011. Epub 2010 Jun 3.

PMID:
20605340
6.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.

Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e237-43. doi: 10.1016/j.ijrobp.2011.03.043. Epub 2011 May 27.

PMID:
21620580
7.

Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.

Mitsudo K, Koizumi T, Iida M, Iwai T, Oguri S, Yamamoto N, Itoh Y, Kioi M, Hirota M, Tohnai I.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e639-45. doi: 10.1016/j.ijrobp.2012.02.057. Epub 2012 Apr 28.

PMID:
22543212
8.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

9.

Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.

Mitsudo K, Koizumi T, Iida M, Iwai T, Nakashima H, Oguri S, Kioi M, Hirota M, Koike I, Hata M, Tohnai I.

Radiother Oncol. 2014 May;111(2):306-10. doi: 10.1016/j.radonc.2014.03.005. Epub 2014 Apr 17.

PMID:
24746571
11.

Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.

Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M.

Acta Otolaryngol. 2013 Mar;133(3):318-26. doi: 10.3109/00016489.2012.744144. Epub 2012 Nov 15.

PMID:
23153059
12.

An essential dose of cisplatin for super-selective intra-arterial infusion concomitant with radiotherapy in patient with maxillary squamous cell carcinoma.

Kanazawa Y, Shojaku H, Takakura H, Fujisaka M, Tachino H, Watanabe Y, Tomizawa G, Kawabe H, Shojaku H, Seto H, Otani K, Fukuoka J.

Eur Arch Otorhinolaryngol. 2012 Aug;269(8):1985-91. doi: 10.1007/s00405-011-1857-7. Epub 2011 Dec 7.

PMID:
22146863
13.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1705-15.

14.
15.

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.

Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, Pallini A, Nascimben O, Biason R, Oniga F, Medici M, Rossi F, Fila G.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):481-7.

PMID:
15145166
16.

Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.

Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M.

Acta Otolaryngol. 2013 Jun;133(6):633-40. doi: 10.3109/00016489.2012.759275. Epub 2013 Feb 11.

PMID:
23394224
17.
18.

Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.

Takayama K, Nakamura T, Takada A, Makita C, Suzuki M, Azami Y, Kato T, Hayashi Y, Ono T, Toyomasu Y, Hareyama M, Kikuchi Y, Daimon T, Mitsudo K, Tohnai I, Fuwa N.

J Cancer Res Clin Oncol. 2016 Mar;142(3):659-67. doi: 10.1007/s00432-015-2069-0. Epub 2015 Oct 31.

PMID:
26521257
19.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
Items per page

Supplemental Content

Write to the Help Desk